Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital

British Journal of Clinical Pharmacology

Volumn 61, Issue 5, 2006, Pages 585-591

  Muller, Arno ^a   Monnet, Dominique L ^b   Talon, Daniel ^a   Hénon, Thierry ^a   Bertrand, Xavier ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Antimicrobial use; Defined daily dose; Hospital; Indicators

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; GLYCOPEPTIDE; LINCOSAMIDE DERIVATIVE; MACROLIDE; METRONIDAZOLE; NORFLOXACIN; OFLOXACIN; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; PRISTINAMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN DERIVATIVE; TEICOPLANIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; COMPUTER SYSTEM; DOSE RESPONSE; DRUG USE; HUMAN; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION REVIEW; FRANCE; GUIDELINE ADHERENCE; HOSPITALS, UNIVERSITY; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; WORLD HEALTH ORGANIZATION;

EID: 33646241070     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02605.x     Document Type: Article

References (24)

1. Bronzwaer SL Cars O Buchholz U Molstad S Goettsch W Veldhuijzen IK Kool JL Sprenger MJ Degener JE A European study on the relationship between antimicrobial use and antimicrobial resistance Emerg Infect Dis 2002 8 278 82
2. Goldmann DA Huskins WC Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide Clin Infect Dis 1997 24 Suppl 1 S139 45
3. Goldmann DA Weinstein RA Wenzel RP Tablan OC Duma RJ Gaynes RP Schlosser J Martone WJ Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership JAMA 1996 275 234 40
4. National Agency for the Development of Medical Evaluation. Proper use of antibiotics in hospital. Recommendations for the control of bacterial resistance Press Med 1998 27 1687 8
5. WHO Collaborating Centre for Drug Statistics and Methodology Guidelines for ATC Classification and DDD Assignment Oslo, Norway WHO 2003
6. Goossens H Ferech M Vander Stichele R Elseviers M Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Lancet 2005 365 579 87
7. Baquero F Baquero-Artigao G Canton R Garcia-Rey C Antibiotic consumption and resistance selection in Streptococcus pneumoniae J Antimicrob Chemother (50 Suppl 2002 S2 27 37
8. Coenen S Mölstad S Preferred antibiotics, dosages and length of treatments in general practice - a comparison between ten European countries Eur J Gen Pract 2004 10 166 8
9. Monnet DL Mölstad S Cars O Defined daily doses of antimicrobials reflect antimicrobial prescriptions in ambulatory care J Antimicrob Chemother 2004 53 1109 11
10. Rogues AM Placet-Thomazeau B Parneix P Vincent I Ploy MC Marty N Merillou B Labadie JC Gachie JP Use of antibiotics in hospitals in south-western France J Hosp Infect 2004 58 187 92
11. Loeffler JM Garbino J Lew D Harbarth S Rohner P Antibiotic consumption, bacterial resistance and their correlation in a Swiss University hospital and its adult intensive care units Scand J Infect Dis 2003 35 843 50
12. Muller-Pebody B Muscat M Pelle B Klein BM Brandt CT Monnet DL Increase and change in pattern of hospital antimicrobial use, Denmark, 1997-2001 J Antimicrob Chemother 2004 54 1122 6
13. Janknegt R Oude Lashof A Gould IM van der Meer JW Antibiotic use in Dutch hospitals1991-1996 J Antimicrob Chemother 2000 45 251 6
14. Filius PM Liem TB van der Linden PD Janknegt R Natsch S Vulto AG Verbrugh HA An additional measure for quantifying antibiotic use in hospitals J Antimicrob Chemother 2005 55 805 8
15. Muller A Lopez-Lozano JM Bertrand X Talon D Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae J Antimicrob Chemother 2004 54 173 7
16. Westh H Zinn CS Rosdahl VT An international multicenter study of antimicrobial consumption and resistance in Staphylococcus aureus isolates from 15 hospitals in 14 countries Microb Drug Resist 2004 10 169 76
17. Muller A Mauny F Bertin M Cornette C Lopez-Lozano JM Viel JF Talon D Bertrand X Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French University hospital Clin Infect Dis 2003 36 971 8
18. Kern WV Steib-Bauert M de With K Reuter S Bertz H Frank U von Baum H Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two University hospitals 1999-2002 J Antimicrob Chemother 2005 55 57 60
19. WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD index Available from: URL. 2005
20. AFSSAPS. Guidelines for the antibiotic treatment of lower respiratory track infections Rev Mal Respir 2003 20 462 9
21. Mandy B Koutny E Cornette C Woronoff-Lemsi MC Talon D Methodological validation of monitoring indicators of antibiotics use in hospitals Pharm World Sci 2004 26 90 5
22. de With K Bergner J Buhner R Dorje F Gonnermann C Haber M Hartmann M Rothe U Strehl E Steib-Bauert M Kern WV Antibiotic use in German University hospitals 1998-2000 (Project INTERUNI-II) Int J Antimicrob Agents 2004 24 213 8
23. Weinstein RA Controlling antimicrobial resistance in hospitals. Infection control and use of antibiotics Emerg Infect Dis 2001 7 188 92
24. Meyer E Schwab F Jonas D Rueden H Gastmeier P Daschner FD Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI). 1. Antimicrobial use in German intensive care units Intensive Care Med 2004 30 1089 96